Healthcare Innovation

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences initiates what it calls the first Phase I trial of an AI-designed oral drug formulation, approved by the UK's MHRA.

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I study of an AI-designed oral formulation, cleared by the MHRA—marking a concrete shift from AI experimentation to clin

Why Does Benchmark’s Work Need More Visibility

In an industry defined by rapid scientific breakthroughs, Benchmark Products plays a quietly pivotal role—translating innovation into tangible tools that life sciences manufacturers can actually use. By staying aligned with the evolving needs of patients and producers alike, Benchmark has built a reputation for agility, rapidly manufacturing solutions that improve efficiency and enable new…

AI-Driven Amino Acid Drugs Surface as a Promising Treatment for Eye Conditions

The rapid evolution of artificial intelligence (AI) promises to revolutionize multiple sectors, and one area seeing tangible benefits is drug development. Historically, the creation of new medicines was a time-consuming endeavor, but AI-driven amino acid research is proving to accelerate the early developmental stages and get drugs to the market faster. Researchers at the Wilmer…